Methods of treating a Flaviviridae family viral infection and compositions for treating a Flaviviridae family viral infection
US9061010B2 · kind B2 · utility
0Cited by
12References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2008 |
| Grant date | Jun 23, 2015 |
| Priority date | — |
| Expiry date | Apr 2, 2030 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Briefly described, embodiments of this disclosure include compositions, pharmaceutical compositions, methods of treating a host infected with a virus from the Flaviviridae family of viruses, methods of treating HCV replication in a host, methods of inhibiting the binding of NS4B polypeptide to the 3′UTR of HCV negative strand RNA in a host, methods of treating liver fibrosis in a host, and the like.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.